1 asset in Systemic Mastocytosis With An Associated Clonal Hematologic Non-Mast Cell Lineage Disease

Therapeutic assets addressing Systemic Mastocytosis With An Associated Clonal Hematologic Non-Mast Cell Lineage Disease, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Bezuclastinib Systemic Mastocytosis With An Associated Clonal Hematologic Non-Mast Cell Lineage Disease	Cogent Biosciences, Inc.	P2	CCC (53)